Navidea biopharma posts q3 loss per share of $0.17

Navidea biopharmaceuticals reports third quarter 2019 financial results.q3 revenue $237,000 versus $231,000.q3 loss per share $0.17.ended q3 of 2019 with $2.8 million in cash and investments.

NAVB Ratings Summary

NAVB Quant Ranking